ARCHIVES

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

DeVita Reshuffling NCI Office Space

April 18, 1980

Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured

June 16, 1989

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

NCI Gets Out of the News Business

January 25, 2013

Call to Shift Two-Thirds Of Funds a “Rubber Number,” Bailar Says

June 6, 1997